What is Parkside compostable packaging?

It is a line of flexible packs that now includes metallised, cellulose‑based films designed to keep oxygen and moisture out, then break down in home compost in about 26 weeks. It targets brands that need strong shelf life without plastic laminates, especially in snacks, coffee, and nutraceuticals.

Which Swiss products fit best for early trials?

Dry snacks, biscuits, chocolate bars, coffee, tea, and powdered supplements are strong candidates. These goods need odor and moisture control but do not require retort or freezer strength. Flow‑wraps, stick‑packs, and sachets are practical formats for Swiss packers to test on existing lines with minor changeovers.

How do compostable films compare to recyclable mono‑plastics?

Recyclable mono‑PE or mono‑PP may be cheaper and use current recycling streams, but they can struggle to match oxygen or moisture barriers without extra layers. Home compostable options reduce plastic and offer consumer‑friendly disposal at home. Each route has trade‑offs in cost, barrier strength, and infrastructure fit.

What should investors in Switzerland monitor next?

Look for confirmed pilots, repeat orders, and in‑store shelf life results. Check lead times, minimum order sizes, and pricing versus mono‑plastics and paper. Policy shifts that value plastic reduction, plus clear on‑pack disposal guidance, will also shape adoption and margin potential in the Swiss market.

Global Market Insights

March 6: Parkside Launches Home‑Compostable Metallised Films for FMCG

ByDanny Kontos March 6, 2026

Parkside compostable packaging now includes home‑compostable metallised films that raise oxygen and moisture barriers while breaking down in around 26 weeks. This matters for Swiss FMCG and nutraceutical brands that need shelf life without plastic laminates. The launch could shift packaging choices, logistics, and sustainability claims in CH. We explain performance, fit for Swiss categories, cost impacts, and what investors should track as home compostable films move from trials to broader use.